|
| |
suppremol Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
SuppreMol Closes EUR 15.7 M Series B Financing Round - News ...
Martinsried/Munich, Germany, July 14, 2008 -- SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103131...
|
BioPortfolio - SuppreMol GmbH - Profile
View the current SuppreMol GmbH Page on BioPortfolio.com ... SuppreMol GmbH is a private biotechnology company located in Martinsried near Munich, Germany, ...
http://www.bioportfolio.com/biocorporate/30581-SuppreMol+Gmb...
|
SuppreMol Announces Expansion of its Management Team and Board ...
Martinsried/Munich, Germany, October 21, 2008 -- SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment
...
http://www.biospace.com/news_story.aspx?NewsEntityId=113838...
|
BioPortfolio - Biocorporate Search Antibody
SuppreMol GmbH is a private biotechnology company located in Martinsried near Munich, Germany, and is focused on the development of novel therapeutics for ...
http://www.bioportfolio.com/biocorporate/Antibody-companies....
|
BioSpace - SuppreMol News, Search Jobs, Events
SuppreMol Announces Expansion of its Management Team and Board Changes ... SuppreMol Closes EUR 15.7 M Series B Financing Round 7/14/2008 7:04:40 AM More.
...
http://www.biospace.com/company_profile.aspx?CompanyId=10048...
|
Exit strategies in Europe : Article : Bioentrepreneur
Peter Buckel is at SuppreMol, Am Klopferspitz 19, 82152 Martinsried, Germany. .... Peter Buckel: CEO of SuppreMol, a startup company based in Martinsried, ...
http://www.nature.com/bioent/2006/060801/full/bioent911.html...
|
SuppreMol Receives Orphan Drug Designation for SM101 - News ...
12, 2007 -- SuppreMol GmbH today announced that the European Commission has granted orphan medicinal product designation for Suppre- Mol‘s lead product ...
http://www.biospace.com/news_story.aspx?NewsEntityId=69497...
|
High synovial expression of the inhibitory FcγRIIb in rheumatoid ...
Dr Uwe Jacob declares a commercial interest in SuppreMol GmbH. He is one of the cofounders and shareholders of SuppreMol, which develops FcγR agonists and ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
Bioentrepreneur - Building a Business - Exit strategies in Europe
29 Aug 2006 ... *Peter Buckel is at SuppreMol, Am Klopferspitz 19, .... Peter Buckel: CEO of SuppreMol, a startup company based in Martinsried, ...
http://www.nature.com/bioent/building/planning/082006/full/b...
|
BioMed Central | author index
Jacob, Uwe SuppreMol, Am Klopferspitz 19, Martinsried, 821 52, Germany. Articles published by BioMed Central. Research article ...
http://www.biomedcentral.com/profiles/authorindex/default.as...
|
|
